
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
AMRI will close its DDS facility in Syracuse, NY.
AMRI
reported that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, NY site to other sites within AMRI and will terminate all operations in Syracuse by the end of June 2014.
As part of the transition, Syracuse DDS capabilities and some employees will be transferred to other AMRI facilities, including Albany, NY; Cedarburg, Wis.; Holywell, UK; and Hyderabad, India. AMRI expects the closure will generate annual run-rate savings of approximately $1.5 million.
Source:
AMRI






